2024版KDIGO《慢性肾脏病评估与管理临床实践指南》更新要点及解读  

Key updates and interpretation of KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

作　　者：杨超 张路霞[1] 赵明辉[1] YANG Chao;ZHANG Lu-xia;ZHAO Ming-hui(Renal Division,Department of Medicine,1 Peking University First Hospital,Peking University Institute of Nephrology,Beijing 100034,China)

机构地区：[1]北京大学第一医院肾脏内科,北京大学肾脏病研究所,北京100034

出　　处：《中国实用内科杂志》2024年第6期457-460,共4页Chinese Journal of Practical Internal Medicine

基　　金：国家自然科学基金(72125009);国家重点研发计划(2022YFF1203001)。

摘　　要：慢性肾脏病(CKD)作为一种病因复杂、证据匮乏的慢性疾病,其评估与管理一直是医疗卫生系统面临的重要挑战。随着医学研究证据不断积累,肾脏疾病的评估与管理策略也在不断完善。基于此,改善全球肾脏病预后组织(KDIGO)于2024年3月再次发布了CKD评估与管理临床实践指南。该指南更推荐准确全面的CKD评估和以患者为中心的管理策略,并强调综合性治疗手段的重要性,包括药物治疗、营养干预和生活方式管理等,以全方位地控制CKD进展。本文针对该指南主要更新内容进行解读,以期为CKD相关临床实践提供有益参考,建议广大医生或相关领域从业者积极学习该指南,结合患者具体情况和临床实际、将其融入到日常诊疗实践中。Chronic kidney disease,as a chronic disease with complex etiology and limited evidence,has always been an important challenge for the healthcare system in terms of assessment and management.With the accumulation of research evidence,the evaluation and management strategies for kidney disease are also constantly improving.Based on this,the Kidney Disease:Improving Global Outcomes(KDIGO)released the Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in March 2024.This guide recommends accurate and comprehensive CKD assessment and patient-centered management strategies,and emphasizes the importance of comprehensive treatment methods,including drug therapy,nutritional intervention,and lifestyle management,to control the progression of CKD in every aspect.This article interprets the key updates of this guideline in order to provide useful reference for clinical practice related to CKD.It is recommended that doctors or practitioners in related fields actively learn this guideline,and integrate it into daily diagnosis and treatment based on the specific situation of patients and clinical practice.

关 键 词：慢性肾脏病 管理 评估 指南 

分 类 号：R692[医药卫生—泌尿科学]